ReMinded Inc

Contact information
Annika Lundström
CEO
New York City, New York
Share on:
Mini-bio

ReMinded is building a clinical-grade,saliva test for cortisol (stres hormone) that bring lab-quality insights closer to patients and clinicians, bridging the gap between centralized labs and consumer wellness.

Core goals

We’re currently at a key inflection point: our quantitative saliva cortisol performance data is being finalized here in NYC, and we’re moving into the final phase of clinical validation ahead of a De Novo FDA clearance. This milestone meaningfully de-risks both the technology and regulatory trajectory toward commercialization. With this, we’re raising a $3M Seed round focused on final clinical validation, regulatory readiness and system integration.

ESG Subnetwork
Join this Subnetwork
Innovation Subnetwork
Join this Subnetwork
Investor Subnetwork
Members (2)
Join this Subnetwork
ESG roadmap
Created on: Jan, 22 2026